Role of Arginase 2 as a potential pharmacological target for the creation of new drugs to correct cardiovascular diseases
Introduction: The review provides relevant information about arginase 2, the role of this enzyme in the formation of endothelial dysfunction and, as a consequence, the development of cardiovascular diseases. History of the discovery of arginase and its func...
Main Authors: | Sergey A. Demchenko, Ivan S. Koklin, Natalia Yu. Koklina |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2020-03-01
|
Series: | Research Results in Pharmacology |
Online Access: | https://rrpharmacology.pensoft.net/article/50942/download/pdf/ |
Similar Items
-
Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension
by: Ivan S. Koklin, et al.
Published: (2019-09-01) -
USE OF SELECTIVE INHIBITORS OF ARGINASE 2 AND TADALAFIL IN COMBINED COMPENSATION OF HOMOCYSTEINE-INDUCED ENDOTHELIAL DYSFUNCTION
by: Ivan Koklin
Published: (2015-12-01) -
Arginase Inhibitor in the Pharmacological Correction of Endothelial Dysfunction
by: Mihail V. Pokrovskiy, et al.
Published: (2011-01-01) -
Search for new pharmacological targets for increasing the efficiency of correction of cardiovascular diseases
by: Liliya V. Korokina, et al.
Published: (2019-09-01) -
Arginase II - a new target in the development of endothelium protectors
by: V. I. Yakushev, et al.
Published: (2018-02-01)